Daniel B Brown

Summary

Publications

  1. ncbi Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies
    Daniel B Brown
    Mallinckrodt Institute of Radiology, St. Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:217-23. 2006
  2. ncbi Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation
    William C Chapman
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA
    Ann Surg 248:617-25. 2008
  3. ncbi Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival
    Ankit Bharat
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, 660 S, Euclid Avenue, St Louis, MO 63110, USA
    J Am Coll Surg 203:411-20. 2006
  4. ncbi Hepatic arterial chemoembolization for management of metastatic melanoma
    Karun V Sharma
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 190:99-104. 2008
  5. ncbi Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:225-32. 2006
  6. ncbi Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:1661-6. 2005
  7. ncbi Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 190:608-15. 2008
  8. ncbi Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Siteman Cancer Center, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 15:1209-18. 2004
  9. ncbi Percutaneous biopsy before interventional oncologic therapy: current status
    Daniel B Brown
    Division of Cardiovascular and Interventional Radiology, Thomas Jefferson University, 111 South 11th Street, Philadelphia, PA 19107, USA
    J Vasc Interv Radiol 19:973-9. 2008
  10. ncbi Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    J Vasc Interv Radiol 18:1469-78. 2007

Collaborators

Detail Information

Publications19

  1. ncbi Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies
    Daniel B Brown
    Mallinckrodt Institute of Radiology, St. Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:217-23. 2006
  2. ncbi Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation
    William C Chapman
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St Louis, MO 63110, USA
    Ann Surg 248:617-25. 2008
    ....
  3. ncbi Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival
    Ankit Bharat
    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, 660 S, Euclid Avenue, St Louis, MO 63110, USA
    J Am Coll Surg 203:411-20. 2006
    ..LRT substantially downstages the primary tumor and improves longterm survival in patients with advanced disease. Complete tumor necrosis with LRT is associated with excellent longterm recurrence-free survival...
  4. ncbi Hepatic arterial chemoembolization for management of metastatic melanoma
    Karun V Sharma
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 190:99-104. 2008
    ..However, the reports of outcomes are limited. We present our outcomes with hepatic arterial chemoembolization for metastasis of stage 4 melanoma...
  5. ncbi Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:225-32. 2006
  6. ncbi Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:1661-6. 2005
    ..The optimal embolic agent for transhepatic arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) has not been identified. This study reports outcomes of TACE for HCC with Gelfoam powder and polyvinyl alcohol (PVA)...
  7. ncbi Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    AJR Am J Roentgenol 190:608-15. 2008
    ....
  8. ncbi Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Siteman Cancer Center, Washington University Medical Center, 510 South Kingshighway Boulevard, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 15:1209-18. 2004
    ..To compare the value of the Child-Pugh and Model for End-stage Liver Disease (MELD) scores to predict patient survival rates after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)...
  9. ncbi Percutaneous biopsy before interventional oncologic therapy: current status
    Daniel B Brown
    Division of Cardiovascular and Interventional Radiology, Thomas Jefferson University, 111 South 11th Street, Philadelphia, PA 19107, USA
    J Vasc Interv Radiol 19:973-9. 2008
  10. ncbi Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    J Vasc Interv Radiol 18:1469-78. 2007
    ....
  11. ncbi Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up
    Chanda K Ho
    Department of Internal Medicine, Washington University School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 18:1451-3. 2007
    ....
  12. ncbi Practice building in interventional oncology
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO 63110, USA
    Tech Vasc Interv Radiol 9:90-5. 2006
    ..In this article, practical methods to target and expand individual practices are addressed along with ways to use physician extenders to maximize efficiency in practice...
  13. ncbi Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors
    Alexander S Ho
    Division of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd, Box 8131, Saint Louis, MO 63110, USA
    AJR Am J Roentgenol 188:1201-7. 2007
    ..Long-term outcome data are limited. We present our experience in the use of hepatic artery chemoembolization in the treatment of patients with hepatic metastasis from neuroendocrine tumors...
  14. ncbi Use of a hybrid fluoroscopic/three-dimensional tomographic unit to assist in targeting a hepatic metastasis for thermal ablation
    Dennis E Der
    J Vasc Interv Radiol 18:583-4. 2007
  15. ncbi Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy
    Ravi Murthy
    Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Vasc Interv Radiol 18:553-61; quiz 562. 2007
    ..Our aim is to increase the understanding of the role of various imaging and preventative techniques in minimizing this undesired effect...
  16. ncbi Pharmacokinetics after endovascular lung perfusion with Cisplatin
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Boulevard, Box 8131, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 17:883-8. 2006
    ..Endovascular lung perfusion (ELP) is a technique designed to deliver high doses of cisplatin via the pulmonary artery for the treatment of lung tumors. The purpose of the current study was to evaluate variables that affect adduct formation...
  17. ncbi Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma
    Shannon G Lehner
    St. Louis University School of Medicine, St. Louis, MO, USA
    AJR Am J Roentgenol 185:1307-9. 2005
  18. ncbi Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system
    Craig B Glaiberman
    Mallinckrodt Institute of Radiology, 510 South Kingshighway Boulevard, Box 8131, St. Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:1341-8. 2005
    ..Given this limitation, the majority of small hepatic neoplasms can still be successfully treated with RFA...
  19. ncbi Endovascular lung perfusion using high-dose cisplatin: uptake and DNA adduct formation in an animal model
    Daniel B Brown
    Mallinckrodt Institute of Radiology, Alvin J Siteman Cancer Center, St Louis, MO 63110, USA
    Oncol Rep 11:237-43. 2004
    ..Further study of ELP evaluating the acute and chronic effects of repeated treatment administration is warranted...